| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.085 | 0.06 |